Gilder Gagnon Howe & CO LLC Argenx Se Transaction History

Gilder Gagnon Howe & CO LLC

$7.87 Billion
Q3 2024

A detailed history of Gilder Gagnon Howe & CO LLC transactions in Argenx Se stock. As of the latest transaction made, Gilder Gagnon Howe & CO LLC holds 3,909 shares of ARGX stock, worth $2.44 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

3,909

Previous 3,833 1.98%

Holding current value

$2.44 Million

Previous $1.65 Million 28.64%

% of portfolio

0.03%

Previous 0.02%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$434.22 - $551.9 $33,000 - $41,944	76 Added 1.98%	3,909 $2.12 Million
Q2 2024 Aug 14, 2024	SELL	$356.01 - $451.55 $24,208 - $30,705	-68 Reduced 1.74%	3,833 $1.65 Million
Q1 2024 May 15, 2024	SELL	$356.95 - $413.29 $1.64 Million - $1.9 Million	-4,607 Reduced 54.15%	3,901 $1.54 Million
Q4 2023 Feb 14, 2024	SELL	$338.91 - $506.01 $379,579 - $566,731	-1,120 Reduced 11.63%	8,508 $3.24 Million
Q3 2023 Nov 14, 2023	SELL	$369.35 - $548.43 $359,746 - $534,170	-974 Reduced 9.19%	9,628 $4.73 Million
Q2 2023 Aug 14, 2023	BUY	$360.14 - $422.58 $324,846 - $381,167	902 Added 9.3%	10,602 $4.13 Million
Q1 2023 May 15, 2023	SELL	$334.23 - $403.65 $16,043 - $19,375	-48 Reduced 0.49%	9,700 $3.61 Million
Q4 2022 Feb 14, 2023	SELL	$342.17 - $402.31 $5,816 - $6,839	-17 Reduced 0.17%	9,748 $3.69 Million
Q3 2022 Nov 14, 2022	SELL	$343.2 - $395.75 $401,200 - $462,631	-1,169 Reduced 10.69%	9,765 $3.45 Million
Q2 2022 Aug 15, 2022	BUY	$269.58 - $378.88 $6,200 - $8,714	23 Added 0.21%	10,934 $4.14 Million
Q1 2022 May 16, 2022	SELL	$254.45 - $351.06 $32,824 - $45,286	-129 Reduced 1.17%	10,911 $3.44 Million
Q4 2021 Feb 14, 2022	SELL	$272.01 - $353.03 $33 Million - $42.8 Million	-121,220 Reduced 91.65%	11,040 $3.87 Million
Q3 2021 Nov 15, 2021	SELL	$295.0 - $350.58 $118,295 - $140,582	-401 Reduced 0.3%	132,260 $39.9 Million
Q2 2021 Aug 16, 2021	BUY	$257.11 - $319.92 $2,313 - $2,879	9 Added 0.01%	132,661 $39.9 Million
Q1 2021 May 17, 2021	SELL	$268.3 - $380.31 $742,654 - $1.05 Million	-2,768 Reduced 2.04%	132,652 $36.5 Million
Q4 2020 Feb 16, 2021	SELL	$248.13 - $308.36 $337,208 - $419,061	-1,359 Reduced 0.99%	135,420 $39.8 Million
Q3 2020 Nov 16, 2020	SELL	$215.51 - $272.51 $760,534 - $961,687	-3,529 Reduced 2.52%	136,779 $35.9 Million
Q2 2020 Aug 14, 2020	BUY	$127.44 - $232.72 $17.1 Million - $31.2 Million	134,093 Added 2157.57%	140,308 $31.6 Million
Q1 2020 May 15, 2020	BUY	$108.83 - $165.23 $1,850 - $2,808	17 Added 0.27%	6,215 $819,000
Q4 2019 Feb 14, 2020	SELL	$106.59 - $164.21 $15.2 Million - $23.4 Million	-142,756 Reduced 95.84%	6,198 $995,000
Q3 2019 Nov 14, 2019	BUY	$113.31 - $150.51 $16.9 Million - $22.4 Million	148,954 New	148,954 $17 Million

Others Institutions Holding ARGX

# of Institutions

400

Shares Held

30.9M

Call Options Held

376K

Put Options Held

489K

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $34.5B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.

Account

Gilder Gagnon Howe & CO LLC Argenx Se Transaction History